Literature DB >> 28904123

Unveiling the Peptide Motifs of HLA-C and HLA-G from Naturally Presented Peptides and Generation of Binding Prediction Matrices.

Moreno Di Marco1, Heiko Schuster1,2, Linus Backert1,3, Michael Ghosh1, Hans-Georg Rammensee1, Stefan Stevanović4.   

Abstract

The classical HLA-C and the nonclassical HLA-E and HLA-G molecules play important roles both in the innate and adaptive immune system. Starting already during embryogenesis and continuing throughout our lives, these three Ags exert major functions in immune tolerance, defense against infections, and anticancer immune responses. Despite these important roles, identification and characterization of the peptides presented by these molecules has been lacking behind the more abundant HLA-A and HLA-B gene products. In this study, we elucidated the peptide specificities of these HLA molecules using a comprehensive analysis of naturally presented peptides. To that end, the 15 most frequently expressed HLA-C alleles as well as HLA-E*01:01 and HLA-G*01:01 were transfected into lymphoblastoid C1R cells expressing low endogenous HLA. Identification of naturally presented peptides was performed by immunoprecipitation of HLA and subsequent analysis of HLA-bound peptides by liquid chromatographic tandem mass spectrometry. Peptide motifs of HLA-C unveil anchors in position 2 or 3 with high variances between allotypes, and a less variable anchor at the C-terminal end. The previously reported small ligand repertoire of HLA-E was confirmed within our analysis, and we could show that HLA-G combines a large ligand repertoire with distinct features anchoring peptides at positions 3 and 9, supported by an auxiliary anchor in position 1 and preferred residues in positions 2 and 7. The wealth of HLA ligands resulted in prediction matrices for octa-, nona-, and decamers. Matrices were validated in terms of their binding prediction and compared with the latest NetMHC prediction algorithm NetMHCpan-3.0, which demonstrated their predictive power.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28904123     DOI: 10.4049/jimmunol.1700938

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

Review 1.  Mapping the tumour human leukocyte antigen (HLA) ligandome by mass spectrometry.

Authors:  Lena Katharina Freudenmann; Ana Marcu; Stefan Stevanović
Journal:  Immunology       Date:  2018-05-08       Impact factor: 7.397

2.  Mass Spectrometry Based Immunopeptidomics Leads to Robust Predictions of Phosphorylated HLA Class I Ligands.

Authors:  Marthe Solleder; Philippe Guillaume; Julien Racle; Justine Michaux; Hui-Song Pak; Markus Müller; George Coukos; Michal Bassani-Sternberg; David Gfeller
Journal:  Mol Cell Proteomics       Date:  2019-12-17       Impact factor: 5.911

3.  Guidance Document: Validation of a High-Performance Liquid Chromatography-Tandem Mass Spectrometry Immunopeptidomics Assay for the Identification of HLA Class I Ligands Suitable for Pharmaceutical Therapies.

Authors:  Michael Ghosh; Marion Gauger; Ana Marcu; Annika Nelde; Monika Denk; Heiko Schuster; Hans-Georg Rammensee; Stefan Stevanović
Journal:  Mol Cell Proteomics       Date:  2020-01-14       Impact factor: 5.911

4.  Negative trade-off between neoantigen repertoire breadth and the specificity of HLA-I molecules shapes antitumor immunity.

Authors:  Máté Manczinger; Balázs Koncz; Gergő Mihály Balogh; Benjamin Tamás Papp; Leó Asztalos; Lajos Kemény; Balázs Papp; Csaba Pál
Journal:  Nat Cancer       Date:  2021-07-08

5.  ERAP1 Controls the Autoimmune Response against Melanocytes in Psoriasis by Generating the Melanocyte Autoantigen and Regulating Its Amount for HLA-C*06:02 Presentation.

Authors:  Akiko Arakawa; Emma Reeves; Sigrid Vollmer; Yukiyasu Arakawa; Mengwen He; Adrian Galinski; Julia Stöhr; Klaus Dornmair; Edward James; Jörg C Prinz
Journal:  J Immunol       Date:  2021-09-27       Impact factor: 5.422

Review 6.  Contribution of the plasma and lymph Degradome and Peptidome to the MHC Ligandome.

Authors:  Laura Santambrogio; Hans-Georg Rammensee
Journal:  Immunogenetics       Date:  2018-10-20       Impact factor: 2.846

7.  Association of Inhibitory Killer Cell Immunoglobulin-like Receptor Ligands With Higher Plasmodium falciparum Parasite Prevalence.

Authors:  Jean C Digitale; Perri C Callaway; Maureen Martin; George Nelson; Mathias Viard; John Rek; Emmanuel Arinaitwe; Grant Dorsey; Moses Kamya; Mary Carrington; Isabel Rodriguez-Barraquer; Margaret E Feeney
Journal:  J Infect Dis       Date:  2021-07-02       Impact factor: 5.226

8.  Discrimination Between Human Leukocyte Antigen Class I-Bound and Co-Purified HIV-Derived Peptides in Immunopeptidomics Workflows.

Authors:  Thomas Partridge; Annalisa Nicastri; Anna E Kliszczak; Louis-Marie Yindom; Benedikt M Kessler; Nicola Ternette; Persephone Borrow
Journal:  Front Immunol       Date:  2018-04-27       Impact factor: 7.561

9.  High-throughput and Sensitive Immunopeptidomics Platform Reveals Profound Interferonγ-Mediated Remodeling of the Human Leukocyte Antigen (HLA) Ligandome.

Authors:  Chloe Chong; Fabio Marino; HuiSong Pak; Julien Racle; Roy T Daniel; Markus Müller; David Gfeller; George Coukos; Michal Bassani-Sternberg
Journal:  Mol Cell Proteomics       Date:  2017-12-14       Impact factor: 5.911

Review 10.  Human Leukocyte Antigen-Class I Alleles and the Autoreactive T Cell Response in Psoriasis Pathogenesis.

Authors:  Jörg Christoph Prinz
Journal:  Front Immunol       Date:  2018-04-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.